Donald Wuchterl
Director/Miembro de la Junta en ABEONA THERAPEUTICS INC. .
Fortuna: 329 275 $ al 31/05/2024
Origen de la red de primer grado Donald Wuchterl.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Subsidiary | Biotechnology | 26 | |
| Public Company | Pharmaceuticals: Major | 18 | |
Cytovance Biologics, Inc.
 Cytovance Biologics, Inc. BiotechnologyHealth Technology Cytovance Biologics, Inc. operates as a biopharmaceutical contract manufacturing company. It specializes in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. Its services include Cell Line Selection, Cell Culture, Recovery and Purification, Analytical development, Troubleshooting Existing Processes, Final Product Fill and Finish, Technology Transfer, Microbial Fermentation, Purification, Cell banking and storage, and Project management. The company was founded in 2003 and is headquartered in Oklahoma City, OK.
5
| Subsidiary | Biotechnology | 5 |
T-Knife Therapeutics, Inc.
1
| Subsidiary | 1 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Donald Wuchterl a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| Harvard Medical School | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor Private Equity Investor Corporate Officer/Principal Corporate Officer/Principal | |
| VOR BIOPHARMA INC. | Biotechnology | Chairman Chief Executive Officer Investor Relations Contact | |
Enobia Pharma, Inc.
 Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Enobia Pharma, Inc. develops therapies to treat patients with ultra-rare and life-threatening genetic metabolic bone disorders. Its lead product candidate, asfotase alfa or ENB-0040, is a treatment for hypophosphatasia—a life-threatening disease that can cause skeletal deformity, severe muscle weakness and progressive damage to vital organs. The company was founded in 1997 and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Chairman Director/Board Member Corporate Officer/Principal | |
| OCATA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
SCO Capital Partners LLC
 SCO Capital Partners LLC Investment ManagersFinance Founded in 1997, SCO Capital Partners LLC is a venture capital firm located in New York City. The firm is a subsidiary of SCO Financial Group LLC. | Investment Managers | Chief Investment Officer Private Equity Analyst Private Equity Investor | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of Wisconsin | College/University | Doctorate Degree Undergraduate Degree | |
AstraZeneca LP
 AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| MARINUS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Graduate Degree | |
| Dartmouth College | College/University | Undergraduate Degree Doctorate Degree | |
| Yale University | College/University | Masters Business Admin Undergraduate Degree | |
| CYMABAY THERAPEUTICS, INC. | Biotechnology | Chairman Director/Board Member | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| RELYPSA INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| George Washington University | College/University | Undergraduate Degree Graduate Degree | |
| GELESIS INC | Biotechnology | Chairman Chief Tech/Sci/R&D Officer | |
| 501 ACQU | Financial Conglomerates | Director/Board Member Chief Executive Officer | |
| INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
Gilda's Club New York City, Inc.
 Gilda's Club New York City, Inc. Miscellaneous Commercial ServicesCommercial Services Gilda's Club New York City, Inc. provides support services to cancer patients. Its programs include cancer support for all, offsite program, and programs for children and teens with cancer. The company was founded by Gene Wilder, Joanna Bull, Mandy Patinkin, and Joel Siegel in 1995 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Arteaus Therapeutics LLC
 Arteaus Therapeutics LLC BiotechnologyHealth Technology Arteaus Therapeutics LLC develops therapies for migraine prevention. The company was founded by Dave Grayzel and Scott C. Chappel on July 15, 2011 and is headquartered in Cambridge, MA. | Biotechnology | Corporate Officer/Principal Director/Board Member | |
California Life Sciences Association
 California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| State University of New York at Buffalo | College/University | Undergraduate Degree Graduate Degree | |
| SCPHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Human Resources Officer Chief Tech/Sci/R&D Officer | |
Astellas Pharma Europe Ltd.
 Astellas Pharma Europe Ltd. Pharmaceuticals: MajorHealth Technology Astellas Pharma Europe Ltd. engages in the development and sale of pharmaceutical products. The company is headquartered in Addlestone, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| TAYSHA GENE THERAPIES, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Human Resources Officer | |
Arvinas Operations, Inc.
 Arvinas Operations, Inc. BiotechnologyHealth Technology Arvinas Operations, Inc. develops novel therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases. It offers proteolysis-targeting chimera PROTAC-based drugs that induce protein degradation to target and eliminate disease-causing proteins from the body. The company was founded by Craig M. Crews in July 2013 and is headquartered in New Haven, CT. | Biotechnology | Director/Board Member Director/Board Member | |
Emendo Biotherapeutics, Inc.
 Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Emendo Biotherapeutics, Inc. engages in the development of genome editing technology. It specializes in protein engineering, molecular biology, and gene editing systems. The company was founded by David Baram, Lior Izhar, and Rachel Diamant in 2015 and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director of Finance/CFO | |
| ARVINAS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Compass Therapeutics LLC
 Compass Therapeutics LLC BiotechnologyHealth Technology Compass Therapeutics LLC operates as a healthcare industry focusing on biotechnology. It offers drug discovery, development, biologics, oncology and immuno-oncology. The company was founded by Errik B. Anderson and Thomas J. Schuetz in 2014 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| COMPASS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| AVENUE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Women in Bio, Inc.
 Women in Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Women in Bio, Inc. is an organization that supports women in the life sciences industry. The non-profit company is based in Bethesda, MD and has subsidiaries in the United States. The organization has 13 chapters in the United States and is funded by sponsors and partners who are dedicated to supporting diversity and inclusion for women of all ages. Founded in 2002, it offers professional educational programs, peer-to-peer learning, mentoring, and networking opportunities for women at all career levels. Women in Bio was founded by Faith L. Charles and Cynthia Wong Hu. | Miscellaneous Commercial Services | Founder Corporate Officer/Principal | |
VectivBio AG
 VectivBio AG BiotechnologyHealth Technology VectivBio AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli in 2019 and is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member Chairman | |
| PASSAGE BIO, INC. | Biotechnology | Chief Executive Officer Director/Board Member |
Estadísticas
Internacional
| Estados Unidos | 46 |
| Suiza | 4 |
| Canadá | 2 |
| Reino Unido | 2 |
Sectorial
| Health Technology | 31 |
| Consumer Services | 11 |
| Finance | 7 |
| Commercial Services | 5 |
Operativa
| Director/Board Member | 255 |
| Corporate Officer/Principal | 118 |
| Independent Dir/Board Member | 96 |
| Chief Tech/Sci/R&D Officer | 40 |
| Undergraduate Degree | 37 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Jonathan Silverstein | 42 |
| Stephen P. Squinto | 40 |
| Thomas Woiwode | 39 |
| Louis Lange | 35 |
| Kush Parmar | 32 |
| Laura Brege | 27 |
| Jennifer Jarrett | 18 |
| Mark Goldberg | 17 |
| Thomas Schuetz | 17 |
| Scott Morrison | 16 |
| Jeffrey Su | 15 |
| Julie Smith | 15 |
| Percival Barretto-Ko | 15 |
| Faith Charles | 14 |
| Matt Patterson | 14 |
- Bolsa de valores
- Insiders
- Donald Wuchterl
- Conexiones Empresas
